| P/E (FY) | — | Sales (TTM) | ₩84.17B |
| Earnings (TTM) | -₩220.50B | ROE | −44.32% |
| Net Margin | −261.96% | ROIC | −11.58% |
| Debt / Equity | 0.63 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | −22.34% |
HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally, and repairs and inspects lifeboats and fabricates and installs pipes. The company also develops and manufactures biopharmaceutical products such as anti-cancer drugs, biological drugs targeting infectious diseases, medical devices, and quasi-drug products including alcohol swabs and sampling tools. It is additionally involved in e-commerce, investment and financing activities.
| Market Cap | $2.77B | Trading Days | 3951 |
| 52W High | 69200.00 |
| 52W Low | 24150.00 |
| % Off High | −56.07% |
| YTD | −40.16% | 1Y | −37.58% |
| 3Y | −4.85% | 5Y | −10.81% |
| 10Y | 227.49% | Since incept. (ann.) | 18.29% |
| Ann. Volatility (1Y) | 82.43% | Ann. Volatility (3Y) | 81.31% |
| Sharpe (1Y) | −0.18 | Sharpe (3Y) | 0.39 |
| Max Drawdown (1Y) | −62.39% | Max Drawdown (3Y) | −78.77% |
| Beta (3Y, vs SPY) | 1.50 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| IRON | Disc Medicine, Inc. | $2.81B | — |
| GRAL | GRAIL, Inc. | $2.72B | — |
| BLLN | BillionToOne, Inc. | $2.84B | 380.6 |
| ESTA | ESTABLISHMENT LABS HOLDINGS INC. | $2.71B | — |
| XRAY | DENTSPLY SIRONA Inc. | $2.84B | — |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | $2.70B | — |
| TMDX | TransMedics Group, Inc. | $2.70B | 16.0 |
| BEAM | Beam Therapeutics Inc. | $2.68B | — |
| CUE | Cue Biopharma, Inc. | $2.65B | — |
| ATAI | AtaiBeckley Inc. | $2.64B | — |
| BIOA-B.ST | BioArctic AB | $2.93B | — |
| IMNM | Immunome Inc. | $2.62B | — |
